Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gemnelatinib (WO2018077227, implementation example 1) is a tyrosine kinase inhibitor with potential applications in cancer research.
Description | Gemnelatinib (WO2018077227, implementation example 1) is a tyrosine kinase inhibitor with potential applications in cancer research. |
In vitro | Gemnelatinib is a tyrosine kinase inhibitor[1] |
Molecular Weight | 524.6 |
Formula | C30H29FN6O2 |
CAS No. | 2225123-30-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gemnelatinib 2225123-30-6 inhibitor inhibit